a 2018

Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes

OLBERTOVÁ, Helena, Karla PLEVOVÁ, Jitka MALČÍKOVÁ, Jana KOTAŠKOVÁ, Šárka PAVLOVÁ et. al.

Basic information

Original name

Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes

Authors

OLBERTOVÁ, Helena (203 Czech Republic, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), Jitka MALČÍKOVÁ (203 Czech Republic, belonging to the institution), Jana KOTAŠKOVÁ (203 Czech Republic, belonging to the institution), Šárka PAVLOVÁ (203 Czech Republic, belonging to the institution), Michaela ŠPUNAROVÁ (203 Czech Republic, belonging to the institution), Martin TRBUŠEK (203 Czech Republic, belonging to the institution), Veronika NAVRKALOVÁ (203 Czech Republic, belonging to the institution), Barbara KANTOROVÁ (203 Czech Republic, belonging to the institution), Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution), Anna PANOVSKÁ (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution) and Šárka POSPÍŠILOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere, 2018

Other information

Language

English

Type of outcome

Conference abstract

Field of Study

10606 Microbiology

Confidentiality degree

is not subject to a state or trade secret

RIV identification code

RIV/00216224:14740/18:00104529

Organization unit

Central European Institute of Technology

Keywords in English

CLL; evolution; telomere

Tags

Changed: 26/3/2019 15:38, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes, Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes.

Links

LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/0968/2017, interní kód MU
Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)
Investor: Masaryk University, Category A
NV15-29793A, research and development project
Name: Analýza Wnt/PCP jako nástroj pro lepší management chronické lymfocytární leukémie
NV15-30015A, research and development project
Name: Analýza klonální heterogenity chronické lymfocytární leukemie pomoci sekvenování nové generace genu pro B-buněčný receptor. Národní studie.
NV15-31834A, research and development project
Name: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie
692298, interní kód MU
Name: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)
Investor: European Union, Spreading excellence and widening participation